Intervention to Enhance PrEP Persistence

Conditions

• HIV Infection Primary
• HIV Prevention

Eligibility Criteria

Sex

MALE

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• RAMP-It-Up Initiation, Adherence, and Retention Intervention — BEHAVIORAL
  The intervention arm will receive facilitated strengths-based case management (SBCM)-delivered by trained interventionists-to help navigate the PrEP medical care system and support the participant and health care staff in meeting the challenges faced with obtaining PrEP medication (e.g., overcoming insurance barriers or barriers with co-pays). This also includes facilitated integration into the PrEP clinic and obtaining monthly PrEP prescription refills

Study Details

The investigators will conduct a fully powered randomized controlled trial (RCT) to test the effect of a patient navigation intervention for Black/African American (B/AA) men who have sex with men (MSM) on PrEP initiation, adherence and retention in care. B/AA men who have sex with men (MSM) are disproportionately impacted by the HIV/AIDS epidemic in the United States. Pre-exposure prophylaxis (PrEP), a once daily medication, can dramatically reduce HIV acquisition risk. However, social and structural barriers have contributed to suboptimal PrEP initiation, adherence, and retention in care among B/AA MSM. Our prior NIH-funded pilot study (R34MH109371; MPI: Nunn, Chan, Mena) developed and evaluated an Intervention to Retain and Adhere MSM in PrEP (RAMP-IT-UP), a brief strengths-based patient navigation program to enhance PrEP care outcomes among young B/AA MSM. The intervention was found to be highly acceptable among B/AA MSM and demonstrated preliminary effectiveness. Compared to control participants, RAMP-IT-UP participants were statistically more likely to initiate PrEP and adhere to PrEP based on pharmacy fill data and PrEP blood levels. Additionally, RAMP-IT-UP participants were more likely to be retained in PrEP care at the 3-month and 6-month clinical visits. Specific Aim #1 of this study will conduct a fully powered randomized controlled trial (RCT to estimate the effectiveness of RAMP-IT-UP in improving PrEP adherence and care outcomes among B/AA MSM in real-world community health center settings (CHCs). Specific Aim #2 will estimate the cost-effectiveness of RAMP-IT-UP among B/AA MSM attending CHCs compared to standard of care. The investigators will also determine the cost-effectiveness of differing levels of intensity of navigation services to prevent HIV based on data collected in Specific Aim #1. Our goal is to develop a cost-effective intervention that enhances PrEP care outcomes and reduces HIV incidence for B/AA MSM which will be relevant for CHCs across the US. The long-term goal of this work is to decrease HIV incidence among B/AA MSM, which aligns with federal Ending the HIV Epidemic and National HIV/AIDS Strategy goals. This application is led by an experienced team of investigators with a proven track record conducting HIV, PrEP and disparities research in real-world clinical settings.

Key Dates

Start date

Oct 1, 2024

Status verified

Oct 2024

Primary completion

Jul 31, 2028

Completion

Jul 31, 2028

Study Design

Enrollment

300 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Arms

• No Intervention: Standard of Care (Control Arm)
  Standard of care (access to a financial advocate and clinical staff to support, facilitate, and assist in linkage to the established PrEP clinic at study sites and to facilitate initiation of, and obtaining, PrEP medications)
• Experimental: RAMP-It-Up intervention
  The RAMP-It-Up intervention focuses on personalized navigation informed by strengths-based case management. RAMP-It-Up consists of a brief in-person patient navigation session, ongoing bidirectional communication as needed, short (10-minute) phone or text message check-ins with the navigator, strengths-based case management strategies to overcome barriers, optional daily medication text reminders, transportation assistance to clinical visits as needed, and monthly calls to patients' pharmacies to assess prescription pick-up, allowing the navigator to provide real-time support in addressing barriers to PrEP initiation, adherence, and retention in care.

Primary Outcome Measure

PrEP Adherence - Pharmacy Fill Data [ Time Frame: 3 and 12 Month Follow Ups ]

Central Contacts

• Dr. Amy Nunn, ScD
  401-863-6568
  [email protected]

Locations (3)

Find similar trials in Washington D.C., DC

Related Studies

• An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
  Recruiting · Rhode Island Hospital · Jackson, Mississippi
• Client-Centered Care Coordination for Black Men Who Have Sex With Men
  Enrolling By Invitation · University of Maryland, Baltimore · Washington D.C., District of Columbia
• Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health
  Recruiting · Rhode Island Hospital · Providence, Rhode Island
• Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
  Not Yet Recruiting · University of Alabama at Birmingham · Birmingham, Alabama